参考文献/References:
[1] NIAN F G, WANG Y W, YANG M F, et al. Identification the role of necroptosis in rheumatoid arthritis by WGCNA network[J]. Autoimmunity, 2024, 57(1): 2358069.
[2] YANG R Z, YAN L W, XU T H, et al. Injectable bioadhe-sive hydrogel as a local nanomedicine depot for targeted regulation of inflammation and ferroptosis in rheumatoid arthritis [J]. Biomaterials, 2024, 311: 122706.
[3] TSALTSKAN V, FIRESTEIN G S. Targeting fibro-blast-like synoviocytes in rheumatoid arthritis [J]. Cur-rent Opinion in Pharmacology, 2022, 67: 102304.
[4] JEONG Y J, PARK S A, PARK Y H, et al. Anti-inflam-matory effect of the combined treatment of LMT-28 and Kaempferol in a collagen-induced arthritis mouse model[J]. PLoS One, 2024, 19(7): e0302119.
[5] 陆健, 冯萍,吴静,等.类风湿关节炎活动期患者血浆外泌体miRNAs差异表达筛选与生物信息学分析及验证[J].现代检验医学杂志,2024,39(2):62-67. LU J, FENG P, WU J, et al. Bioinformatics analysis and validation of differential expression of miRNAs in plasma exosomes from patients with active rheumatoid arthritis[J]. Journal of Modern Laboratory Medicine, 2024, 39(2): 62-67.
[6] ZHAO L Y, WU Q Z, LONG Y Y, et al. MicroRNAs:critical targets for treating rheumatoid arthritis angiogen-esis[J]. Journal of Drug Targeting, 2024, 32(1): 1-20.
[7] ANDONIAN B J , CHOU C H , ILKAYEVA O R ,et al. Plasma microRNAs in established rheumatoid arthri-tis relate to adiposity and altered plasma and skeletal muscle cytokine and metabolic profiles [J]. Frontiers in Immunology, 2019, 10: 1475.
[8] YUE C R , WANG W Q, GAO S, et al. Agomir miR-NA-150-5p alleviates pristane-induced lupus by sup-pressing myeloid dendritic cells activation and inflam-mation via TREM-1 axis[J]. Inflammation Research, 2023, 72(7): 1391-1408.
[9] WEI S B, LIU Q Y. Long noncoding RNA MALAT1 mod-ulates sepsis-induced cardiac inflammation through the miR-150-5p/NF-κB axis[J]. International Journal of Clini-cal and Experimental Pathology, 2019, 12(9): 3311-3319.
[10] MURATA K, FURU M, YOSHITOMI H, et al. Com-prehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid ar-thritis[J]. PLoS One, 2013, 8(7): e69118.
[11] KONG L L, WANG L F, ZHAO Q, et al. Rhodojapo-nin II inhibits TNF-α-induced inflammatory cytokine secretion in MH7A human rheumatoid arthritis fibro-blast-like synoviocytes[J]. Journal of Biochemical and Molecular Toxicology, 2020, 34(10): e22551.
[12] BAO Y R G, HU S N, SONG Z J, et al. Chinese medi-cine Di-long (Pheretima vulgaris) and its active fraction exhibit anti-rheumatoid arthritis effects by inhibiting CXCL10/CXCR3 chemotaxis in synovium [J]. Journal of Ethnopharmacology, 2024, 332: 118286.
[13] N?METH T, NAGY G, PAP T. Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?[J]. Annals of the Rheumatic Diseases, 2022, 81(8): 1055-1064.
[14] WU Z W, MA D, YANG H L, et al. Fibroblast-like sy-noviocytes in rheumatoid arthritis: Surface markers and phenotypes [J]. International Immunopharmacology, 2021, 93: 107392.
[15] ALIVERNINI S, MACDONALD L, ELMESMARI A, et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid ar-thritis[J]. Nature Medicine, 2020, 26(8): 1295-1306.
[16] ZHANG L, WU H J, ZHAO M, et al. Identifying the differentially expressed microRNAs in autoimmunity:a systemic review and meta-analysis[J]. Autoimmunity, 2020, 53(3): 122-136.
[17] RAO P L, LI J M, XIONG J H, et al. MicroR-NA-150-5p-mediated inhibition of cell proliferation, G1/S transition, and migration in bladder cancer through target-ing NEDD4-binding protein 2-like 1 gene[J]. Journal of Physiological Investigation, 2024, 67(3): 118-128.
[18] CHEN H L, CAI X W, DU B W, et al. MicroR-NA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regu-lating peptidyl-prolyl cis/trans isomerase[J]. Brazilian Journal of Otorhinolaryngology, 2023, 89(3): 383-392.
[19] SHI L, ZHANG Y F, XIA Y, et al. MiR-150-5p protects against septic acute kidney injury via repressing the MEKK3/JNK pathway [J]. Cellular Signalling, 2021, 86: 110101.
[20] HU J C, YANG Z J, WU H, et al. Rhein attenuates renal inflammatory injury of uric acid nephropathy via lin-cRNA-Cox2/miR-150-5p/STAT1 axis [J]. International Immunopharmacology, 2020, 85: 106620.
[21] OU M H, ZHAO H D, JI G X, et al. Long noncoding RNA MALAT1 contributes to pregnancy-induced hyper-tension development by enhancing oxidative stress and inflammation through the regulation of the miR-150-5p/ET-1 axis[J]. FASEB Journal, 2020, 34(5): 6070-6085.
[22] KIM J Y, SEO S M, KIM H W, et al. Protective role of the toll-like receptor 5 agonist KMRC011 against murine colitis induced by citrobacter rodentium and dextran sulfate sodium[J]. Journal of Microbiology and Biotechnology, 2023, 33(1): 35-42.
[23] REFAIE M M M, SHEHATA S, IBRAHIM R A, et al. Dose-dependent cardioprotective effect of hemin in doxorubicin-induced cardiotoxicity via Nrf-2/HO-1 and TLR-5/NF-κB/TNF-α signaling pathways[J]. Cardio-vascular Toxicology, 2021, 21(12): 1033-1044.
[24] WANG Y L, ZHENG F, GAO G H, et al. MiR-548a-3p regulates inflammatory response via TLR4/NF-κB signaling pathway in rheumatoid arthritis[J]. Journal of Cellular Biochemistry, 2019, 120(2): 1133-1140.
[25] PUPPALA E R , PRASAD N , PRAKASH A N, et al.Me-sua assamica (King & Prain) kosterm. bark ethanolic extract attenuates rheumatoid arthritis via down-regulating TLR4/NF-κB/COX-2/iNOS and activation of Nrf2/HO-1 path-ways: a comprehensive study on in-vitro and in-vivo mod-els[J].Journal of Ethnopharmacology, 2024, 335: 118671.
[26] TAKEUCHI T, YOSHIDA H, TANAKA S. Role of inter-leukin-6 in bone destruction and bone repair in rheumatoid arthritis[J]. Autoimmunity Reviews, 2021, 20(9): 102884.
[27] LOZADA-MELLADO M, LLORENTE L, HINOJO-SA-AZAOLA A, et al. Inflammatory profile in patients with rheumatoid arthritis and sarcopenia[J]. Clinical Rheumatology, 2024, 43(6): 1865-1870.
[28] ZHU M C, YE L, ZHU G P, et al. ROS-responsive miR-150-5p downregulation contributes to cigarette smoke-in-duced COPD via targeting IRE1α [J]. Oxidative Medi-cine and Cellular Longevity, 2022, 2022(1): 5695005.
[29] MA Y Z, LIU Y N, HOU H H, et al. MiR-150 predicts survival in patients with sepsis and inhibits LPS-in-duced inflammatory factors and apoptosis by targeting NF-kappaB1 in human umbilical vein endothelial cells[J]. Biochemical and Biophysical Research Com-munications, 2018, 500(3): 828-837.
相似文献/References:
[1]穆亚宏,王 瑞,刘小玲.血清α1-酸性糖蛋白水平对类风湿关节炎疗效的评价[J].现代检验医学杂志,2016,31(01):147.[doi:10.3969/j.issn.1671-7414.2016.01.043]
MU Ya-hong,WANG Rui,LIU Xiao-ling.Evaluation of Serum Alpha 1-Acid Glycoprotein
in Therapeutic Efficiency of Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2016,31(02):147.[doi:10.3969/j.issn.1671-7414.2016.01.043]
[2]沈小辉,喻 伟,杨 菲.类风湿关节炎患者滑膜抗环瓜氨酸肽
表位表达与肽酰基精氨酸脱亚氨酶4基因的相关性分析[J].现代检验医学杂志,2016,31(03):26.[doi:10.3969/j.issn.1671-7414.2016.03.008]
SHEN Xiao-hui,YU Wei,YANG Fei.Relation Analysis of Synovial Anti-Citrullinated
Epitope Peptide Expression and Peptidyl Arginine Deiminase
4 Gene in the Rheumatoid Arthritis Patient[J].Journal of Modern Laboratory Medicine,2016,31(02):26.[doi:10.3969/j.issn.1671-7414.2016.03.008]
[3]赵辉.抗CCP抗体,AKA与RF联合检测在类风湿关节炎诊断中的临床意义[J].现代检验医学杂志,2015,30(05):159.[doi:10.3969/j.issn.1671-7414.2015.05.051]
ZHAO Hui.Clinical Significance of Anti-CCP Antibody and Anti-AKA
Antibody and Rheumatoid Factor in Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2015,30(02):159.[doi:10.3969/j.issn.1671-7414.2015.05.051]
[4]赵 娜,王兴宁,贾良勇.HLA-DR53,anti-Sa和anti-CCP抗体联合检测对诊断类风湿关节炎的临床应用价值[J].现代检验医学杂志,2017,32(02):78.[doi:10.3969/j.issn.1671-7414.2017.02.021]
ZHAO Na1,WANG Xing-ning2,JIA Liang-yong2.Diagnostic Value and Significance of the HLA-DR53,Anti-Sa
and Anti-CCP Antibody Factors Combination in Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2017,32(02):78.[doi:10.3969/j.issn.1671-7414.2017.02.021]
[5]张 微,张润清,于 磊.类风湿关节炎并发贫血女性患者血清铁蛋白检测的临床价值[J].现代检验医学杂志,2018,33(02):118.[doi:10.3969/j.issn.1671-7414.2018.02.001]
ZHANG Wei,ZHANG Run-qing,YU Lei.Clinical Value of Serum Ferritin Detection in Patients
with Rheumatoid Arthritis Complicated with Anemia[J].Journal of Modern Laboratory Medicine,2018,33(02):118.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[6]齐进康,刘佳钰,刘 丹,等.类风湿关节炎患者血清25-OH-VD和SPP1水平检测的临床意义[J].现代检验医学杂志,2018,33(06):35.[doi:10.3969/j.issn.1671-7414.2018.06.009]
QI Jin-kang,LIU Jia-yu,LIU Dan,et al.Study on Clinical Application of 25-Hydroxyvitamin D and Serum Osteopontin in Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2018,33(02):35.[doi:10.3969/j.issn.1671-7414.2018.06.009]
[7]赵芬,张爱萍,赵楠楠,等.类风湿关节炎患者血清IL-27水平及外周血PLR检测与疾病活动度的相关性研究[J].现代检验医学杂志,2019,34(01):34.[doi:10.3969/j.issn.1671-7414.2019.01.009]
ZHAO Fen,ZHANG Ai-ping,et al.Correlation Analysis between Serum IL-27 Levels and Peripheral B
lood
PLR Detection and Disease Activity in Rheumatoid Arthritis Patients[J].Journal of Modern Laboratory Medicine,2019,34(02):34.[doi:10.3969/j.issn.1671-7414.2019.01.009]
[8]焦荣红,沈海涛,王淑芬,等.类风湿关节炎患者血清淀粉样蛋白A和C反应蛋白水平与疾病活动度的关系[J].现代检验医学杂志,2019,34(01):55.[doi:10.3969/j.issn.1671-7414.2019.01.014]
JIAO Rong-hong,SHEN Hai-tao,WANG Shu-fe
n,et al.Relationship between Serum Amyloid A and C-reactive Protein
in Patients with Rheumatoid Arthritis and Activity of Disease[J].Journal of Modern Laboratory Medicine,2019,34(02):55.[doi:10.3969/j.issn.1671-7414.2019.01.014]
[9]周莹,王子铭,虞伟,等.类风湿关节炎免疫学发病机制研究的最新进展[J].现代检验医学杂志,2019,34(01):157.[doi:10.3969/j.issn.1671-7414.2019.01.041]
ZHOU Ying,WANG Zi-ming,YU Wei,et al.New Advances in Immunology Research on
the Pathogenesis of Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2019,34(02):157.[doi:10.3969/j.issn.1671-7414.2019.01.041]
[10]周 莹,管晓龙,李晓军,等.ELISA 检测KRT10_C 和COL6A3_C 短肽抗体的方法建立及作为RA 诊断的应用价值[J].现代检验医学杂志,2020,35(01):1.[doi:10.3969/j.issn.1671-7414.2020.01.001]
ZHOU Ying,GUAN Xiao-long,LI Xiao-jun,et al.Establishment of ELISA for Detection of KRT10_C and COL6A3_C
Short PeptideAntibodies and Its Application as
A Diagnostic Biomarker for RA[J].Journal of Modern Laboratory Medicine,2020,35(02):1.[doi:10.3969/j.issn.1671-7414.2020.01.001]